The most effective AD treatments may also have the greatest risk of adverse events.

A multidisciplinary approach is most effective for treating difficult-to-control AD in children and adolescents.

A website that helps people with eczema manage their symptoms could be saving the U.K. National Health Service (NHS) hundreds of...

IL-23 inhibitors used to treat psoriasis patients are associated with the lowest risk of paradoxical AD compared to other biologics.

The AAAAI/ACAAI JTF has published updated AD guidelines based on new available treatments and evidence-based recommendations.

Abrocitinib is efficacious and well tolerated in AD patients with or without allergic comorbidities.

Pain and pruritus are the main contributors to AD burden and poor health-related QoL.

A survey from the National Eczema Association in the U.S. has revealed that patients with AD tend to experience poor mental health symptoms.